Deciphera Pharmaceuticals (DCPH) Short Interest Ratio & Short Volume → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free DCPH Stock Alerts $25.37 0.00 (0.00%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Deciphera Pharmaceuticals Short Interest DataCurrent Short Volume5,750,000 sharesPrevious Short Volume6,060,000 sharesChange Vs. Previous Month-5.12%Dollar Volume Sold Short$85.68 millionShort Interest Ratio / Days to Cover10.9Last Record DateApril 15, 2024Outstanding Shares82,226,000 sharesFloat Size50,240,000 sharesShort Percent of Float11.45%Today's Trading Volume2,365,170 sharesAverage Trading Volume1,264,416 sharesToday's Volume Vs. Average187% Short Selling Deciphera Pharmaceuticals ? Sign up to receive the latest short interest report for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDCPH Short Interest Over TimeDCPH Days to Cover Over TimeDCPH Percentage of Float Shorted Over Time Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Deciphera Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20245,750,000 shares $85.68 million -5.1%11.5%10.9 $14.90 3/31/20246,060,000 shares $95.32 million +7.3%12.3%11.2 $15.73 3/15/20245,650,000 shares $88.08 million +2.5%11.4%10.6 $15.59 2/29/20245,510,000 shares $91.96 million No Change11.2%9.8 $16.69 2/15/20245,510,000 shares $87.72 million +3.2%11.2%10 $15.92 1/31/20245,340,000 shares $76.47 million +7.4%10.9%9.6 $14.32 Get the Latest News and Ratings for DCPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,970,000 shares $73.75 million +1.2%10.2%7.5 $14.84 12/31/20234,910,000 shares $79.20 million +0.4%10.1%6.9 $16.13 12/15/20234,890,000 shares $78.00 million -15.0%10.1%6.8 $15.95 11/30/20235,750,000 shares $72.51 million +3.6%11.9%8.2 $12.61 11/15/20235,550,000 shares $68.49 million +41.9%11.5%8.6 $12.34 10/31/20233,910,000 shares $46.88 million -3.0%8.1%6 $11.99 10/15/20234,030,000 shares $44.13 million -0.3%8.5%7.9 $10.95 9/30/20234,040,000 shares $51.39 million -7.1%8.5%8.6 $12.72 9/15/20234,350,000 shares $58.38 million +2.4%9.1%10.6 $13.42 8/31/20234,250,000 shares $59.67 million +4.2%7.8%9.9 $14.04 8/15/20234,080,000 shares $63.16 million -1.0%7.5%9.1 $15.48 7/31/20234,120,000 shares $55.70 million +6.5%7.6%9.3 $13.52 7/15/20233,870,000 shares $54.22 million +2.1%7.1%7.8 $14.01 6/30/20233,790,000 shares $53.36 million -14.1%6.7%7.1 $14.08 6/15/20234,410,000 shares $64.12 million +2.3%8.1%7.9 $14.54 5/31/20234,310,000 shares $58.19 million +14.9%8.0%6.9 $13.50 5/15/20233,750,000 shares $53.33 million +11.0%7.0%5.8 $14.22 4/30/20233,380,000 shares $48.03 million +0.3%6.3%4.9 $14.21 4/15/20233,370,000 shares $49.00 million -40.9%6.5%4.5 $14.54 3/31/20235,700,000 shares $88.07 million +6.9%11.0%7.1 $15.45 3/15/20235,330,000 shares $89.22 million -0.7%10.3%6.3 $16.74 2/28/20235,370,000 shares $77.87 million No Change10.3%6.9 $14.50 2/15/20235,370,000 shares $83.13 million +7.6%10.4%7.1 $15.48 1/31/20234,990,000 shares $84.88 million +4.8%10.8%6.9 $17.01 1/15/20234,760,000 shares $102.34 million -33.7%10.0%7 $21.50 12/30/20227,180,000 shares $117.68 million -6.5%15.1%12.4 $16.39 12/15/20227,680,000 shares $120.58 million +7.7%16.1%13.9 $15.70 11/30/20227,130,000 shares $113.44 million -2.9%15.0%11 $15.91 11/15/20227,340,000 shares $115.53 million +2.4%15.5%10.4 $15.74 10/31/20227,170,000 shares $116.30 million -2.9%15.1%9.4 $16.22 10/15/20227,380,000 shares $123.47 million -1.9%15.7%9.1 $16.73 9/30/20227,520,000 shares $139.12 million +0.8%16.0%8.9 $18.50 9/15/20227,460,000 shares $147.86 million -5.1%15.9%8.4 $19.82 8/31/20227,860,000 shares $127.57 million +9.6%16.8%8.4 $16.23Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. DCPH Short Interest - Frequently Asked Questions What is Deciphera Pharmaceuticals' current short interest? Short interest is the volume of Deciphera Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 5,750,000 shares of DCPH short. 11.45% of Deciphera Pharmaceuticals' shares are currently sold short. Learn More on Deciphera Pharmaceuticals' current short interest. What is a good short interest ratio for Deciphera Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DCPH shares currently have a short interest ratio of 11.0. Learn More on Deciphera Pharmaceuticals's short interest ratio. Which institutional investors are shorting Deciphera Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Deciphera Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Deciphera Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.45% of Deciphera Pharmaceuticals' floating shares are currently sold short. Is Deciphera Pharmaceuticals' short interest increasing or decreasing? Deciphera Pharmaceuticals saw a decline in short interest in April. As of April 15th, there was short interest totaling 5,750,000 shares, a decline of 5.1% from the previous total of 6,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Deciphera Pharmaceuticals' float size? Deciphera Pharmaceuticals currently has issued a total of 82,226,000 shares. Some of Deciphera Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Deciphera Pharmaceuticals currently has a public float of 50,240,000 shares. How does Deciphera Pharmaceuticals' short interest compare to its competitors? 11.45% of Deciphera Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Deciphera Pharmaceuticals: Keros Therapeutics, Inc. (6.27%), Amphastar Pharmaceuticals, Inc. (11.01%), Rocket Pharmaceuticals, Inc. (12.12%), Amneal Pharmaceuticals, Inc. (2.51%), Ardelyx, Inc. (14.50%), Edgewise Therapeutics, Inc. (9.15%), Syndax Pharmaceuticals, Inc. (11.30%), NewAmsterdam Pharma (0.85%), Maravai LifeSciences Holdings, Inc. (5.93%), Galapagos NV (2.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Deciphera Pharmaceuticals stock? Short selling DCPH is an investing strategy that aims to generate trading profit from Deciphera Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Deciphera Pharmaceuticals? A short squeeze for Deciphera Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DCPH, which in turn drives the price of the stock up even further. How often is Deciphera Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DCPH, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Keros Therapeutics Short Interest Data Amphastar Pharmaceuticals Short Interest Data Rocket Pharmaceuticals Short Interest Data Amneal Pharmaceuticals Short Interest Data Ardelyx Short Interest Data Edgewise Therapeutics Short Interest Data Syndax Pharmaceuticals Short Interest Data NewAmsterdam Pharma Short Interest Data Maravai LifeSciences Short Interest Data Galapagos Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DCPH) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBiden Nomination CANCELED?The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin Analytics